Pimblett Emily

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
2
Insider Sells Sum
$18,723.35

Insider Activity of Pimblett Emily

According to the SEC Form 4 filings, Pimblett Emily, being in a position of

  1. CHIEF ACCOUNTING OFFICER at Eliem Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 2436 shares for $18,723,
    over all time since 2024-06-20, has bought 0 shares, and sold 2436 shares for $18,723.

The largest sale of all time was on 2024-09-20 and amounted to 1191 share of Eliem Therapeutics, Inc. for $9,741.

Biography of Pimblett Emily

No biography is available at this moment.

2024-09-20SaleEliem Therapeutics, Inc.
ELYM
CHIEF ACCOUNTING OFFICER
1,191
0.0017%
$8.18$9,741-39.38%
2024-06-20SaleEliem Therapeutics, Inc.
ELYM
CHIEF ACCOUNTING OFFICER
1,245
0.0036%
$7.21$8,982-6.19%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.